Shanghai Heartcare Medical Technology Corp. Ltd. Class H (HK:6609) has released an update.
Shanghai HeartCare Medical Technology Corporation Limited has announced the establishment of a new Strategy Committee to enhance its strategic development and corporate governance. The committee, effective from August 30, 2024, aims to improve the company’s core competitiveness and investment decision-making process. Initial members include Ms. Zhang Kun, Mr. Ding Kui, Mr. Chen Gang, with Mr. Wang Guohui serving as the chairman.
For further insights into HK:6609 stock, check out TipRanks’ Stock Analysis page.
